Report on the risk assessment of 2C-1, 2C-T-2 and 2C-T

Zrzut strony: http://bookshop.europa.eu/en/report-on-the-risk-assessment-of-2c-1-2c-t-2-and-2c-t-7-in-the-framework-of-the-joint-action-on-new-synthetic-drugs-pbT D5403396/
This site is part of
About EU Bookshop Frequently asked questions Contact Sitemap General conditions Legal notice
All EU publications YOU are looking for!
English (en)
EUROPA > EU Bookshop > Themes > Social > Social policy > Social problems > Report on the risk assessment of 2C-1, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs
DISCOVER
THEMES
Social policy (2 000)
Social questions - tow n
planning and housing
(54)
AUTHORS
in whole site
SUBSCRIPTIONS
Publication details
My basket
Report on the risk assessment of 2C-1,
2C-T-2 and 2C-T-7 in the framework of
the joint action on new synthetic drugs
Social problems (409)
Demography and
population (179)
Social protection and
social security (224)
European Social Fund
(213)
Advanced search
EMCDDA Risk assessments
The risk-assessment reports on the synthetic drugs 2C -I; 2C -T-2 and 2C T-7 were submitted by the EMC DDA to the European C ouncil and
C ommission on 4 April 2003. The reports were drawn up at a meeting in
Lisbon from 31 March to 1 April under the auspices of an enlarged
EMC DDA Scientific C ommittee. The drugs were singled out by the C ouncil
of the EU for risk assessment on 12 December 2002 under the 1997 Joint
action on new synthetic drugs.The reports conclude that, due to their
structural features, the drugs are potent hallucinogens/stimulants, similar
to substances already classified under Schedules I and II of the 1971 UN
C onvention on Psychotropic Substances. They also note that the
substances have no current medical or industrial use.The reports
recommend that, due to a potential serious health risk, the drugs should
be controlled substances, although some experts consider that insufficient
scientific evidence exists to support such a decision. Experts agreed
however that whatever the control measures chosen, they should
contribute to collecting and disseminating accurate information on the
substances to users, and to relevant professionals for preventive and
harm-reduction purposes.
Track an order
Log in
Username
••••••••
Register
Forgotten your password?
News
Corporate author(s): EMCDDA — European Monitoring Centre for Drugs and
Drug Addiction
Themes: Social problems
Target audience: Specialised/Technical
EuroVoc: European Monitoring Centre for Drugs and Drug Addiction, health
risk, narcotic, drug addiction
PAPER
Details
Identifiers
Pages: 136 _
W eight: 306 g
Publication year: 2003
ISBN: 92-9168-181-4
Available languages:
English
Catalogue number
Price
TD-54-03-396-EN-C
Free
Add to basket
PDF
Details
Identifiers
Publication year: 2004
ISBN: 92-9168-181-4
Available languages:
English
Catalogue number
Price
TD-54-03-396-EN-C
Free
Download cover
Download content
Search
Advanced search
Browse by
Corporate author
Theme
Subscriptions
Practical information
About EU Bookshop
Sales agents
Legal information
General conditions
Disclaimer
Copyright notice
Privacy notice
<--kliknij na adresie